DA-9701 placebo

DRUG2 trials

Sponsors

Seoul National University Hospital, Dong-A ST Co., Ltd.

Conditions

DyspepsiaFunctional DyspepsiaParkinson Disease

Phase 4

Effect of Short-term Motilitone Therapy on Health-related Quality of Life in PD Patients With Gastrointestinal Symptoms

CompletedNCT02775591

Seoul National University HospitalDyspepsia, Parkinson Disease

Start: 2016-04-30End: 2018-12-31Updated: 2019-03-28

A Study to Evaluate the Efficacy and Safety of DA-9701 in Patients With Functional Dyspepsia

RecruitingNCT07686679

Dong-A ST Co., Ltd.Functional Dyspepsia

Start: 2026-08-06End: 2027-10-01Target: 300Updated: 2026-08-10

Related Papers

<scp>Double‐Blind</scp>, Randomized, <scp>Placebo‐Controlled</scp> Trial of <scp>DA</scp>‐9701 in Parkinson's Disease: <scp>PASS</scp>‐<scp>GI</scp> Study

Movement Disorders2020-08-0612 citations